中源协和: 中源协和细胞基因工程股份有限公司十一届九次临时监事会会议决议公告

Core Viewpoint - The company plans to temporarily use idle raised funds to supplement working capital, amounting to no more than 180 million yuan, for a period not exceeding 12 months, without affecting the normal implementation of fundraising projects [1][2]. Group 1 - The temporary use of idle raised funds is aimed at improving the efficiency of fund utilization and reducing financial costs [2]. - The decision complies with relevant regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [2]. - The company assures that this action will not change the purpose of the raised funds or harm the interests of shareholders, especially minority shareholders [2].